- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Ongoing digitizer slump affects Lumisys Q3 results
Ongoing digitizer slump affects Lumisys Q3 resultsA slowdown in the film digitizer market continues to impact the financial performance of film digitizer company Lumisys. The Sunnyvale, CA-based firm reported a 2% increase in revenues for its
Ongoing digitizer slump affects Lumisys Q3 results
A slowdown in the film digitizer market continues to impact the financial performance of film digitizer company Lumisys. The Sunnyvale, CA-based firm reported a 2% increase in revenues for its third quarter.
Although sales showed signs of rebounding, revenues for the period (end-September) were $6 million, compared with $5.9 million for the third quarter in 1996. Net income was $616,000 compared with $817,000 in the same period last year.
The company also reported that the low-cost computed radiography reader it is developing for the medical market is on track for a late-1999 launch (PNN 5/97). Engineers at CompuRad will also be working on the CR project, once that company's acquisition is finalized.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
